Cancer

EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024

Company to host conference call and webcast on Wednesday, August 28th at 8:30am EDT LYON, France, August 7, 2024 --…

2 years ago

Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

Management to host conference call and webcast at 8:30am ETPITTSBURGH, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI),…

2 years ago

Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

-Initiated Phase 2a Study Activities for ATI-2138 in Atopic Dermatitis--Strengthened Balance Sheet Through Sale of Future OLUMIANT® Royalties for Proceeds…

2 years ago

Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update

Sanofi plans to expand KT-474/SAR444656 (IRAK4) Phase 2 clinical trials in HS and AD to accelerate overall development timelines following…

2 years ago

Establishment Labs Reports Second Quarter 2024 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

2 years ago

Personalized Disease Specific Patient Support, Care Coordination, and Virtual Care Delivery Tech Platform Focused on the Less Fortunate

HOUSTON, Aug. 6, 2024 /PRNewswire/ -- Founded in January 2022 Medical Resource Group DBA MRG Health Inc – Smart Care 360…

2 years ago

Cryoport Reports Second Quarter 2024 Financial Results

Revenue improved sequentially across all businessesCommercial Cell & Gene Therapy revenue increased 51% year-over-year and 20% sequentially A record total…

2 years ago

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2024

Core Illumina revenue of $1.09 billion for Q2 2024, down 6% from Q2 2023 (down 6% on a constant currency…

2 years ago

Lindus Health Unveils “All-in-One Dermatology CRO” Offering for Dermatology Clinical Trials

NEW YORK, Aug. 6, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life…

2 years ago

Tuesday Health Unveils Groundbreaking Results from the ePAL Continuous Monitoring Study

Published in the Journal of Pain and Symptom Management, the Study Highlights Significant Advancements Using the ePAL App, now known…

2 years ago